GSK PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 2.2%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 2.2%
Wed, 26 Aug

GSK PHARMA has announced its results for the quarter ended June 2020. Here is a detailed performance review of the same:

GSK PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-19*
3
Mar-20*
3
Jun-20*
QoQ ChangeYoY Change
Net SalesRs m7,8807,7596,487-16.4%-17.7%
Other incomeRs m305152578281.2%89.2%
TurnoverRs m8,1867,9107,064-10.7%-13.7%
ExpensesRs m6,2256,0185,343-11.2%-14.2%
Gross profitRs m1,6551,8541,144-38.3%-30.9%
DepreciationRs m191226218-3.6%14.2%
InterestRs m91511-28.5%16.1%
Profit before taxRs m1,7601,7641,493-15.4%-15.2%
TaxRs m626385383-0.4%-38.7%
Profit after taxRs m1,1351,3791,110-19.6%-2.2%
Gross profit margin%21.023.917.6
Effective tax rate%35.521.825.7
Net profit margin%13.917.415.7
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 17.7% on a year-on-year (YoY) basis. The expenses were down by 14.2% YoY during the same period.
  • The company's operating profit declined by 30.9% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 17.6% in 1QFY21 as against 21.0% in 1QFY20.
  • Depreciation charges increased by 14.2% and finance costs increased by 16.1% YoY, respectively.
  • Other income increased by 89.2% YoY during the quarter.
  • Net profit for the quarter declined by 2.2% YoY. Net profit margins during the quarter increased from 13.9% in 1QFY20 to 15.7% in 1QFY21.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 16.4% on a quarter-on-quarter (QoQ) basis. The expenses were down by 11.2% QoQ during the same period.
  • The company's operating profit declined by 38.3% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 17.6% in 1QFY21 as against 23.9% in 4QFY20.
  • Net profit for the quarter declined by 19.6% QoQ, while net profit margins declined from 17.4% in 4QFY20 to 15.7% in 1QFY21.

To see how GSK PHARMA has performed over the last eight quarters,please visit here.

Free Signup: Learn how India is poised to emerge as a global power

GSK PHARMA Share Price Performance

Over the last one year,GSK PHARMA share price has moved up from Rs 1,207.3 to Rs 1,585.5, registering a Gain of Rs 378.2 or around 31.3%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 19,132.3 (down 0.2%). Over the last one year it has moved up from 12,548.7 to 19,132.3, a gain of 6,584 points (up 52.5%).

Overall, the S&P BSE SENSEX is up 3.6% over the year.

Current Valuations

At the current price of Rs 1,585.5, the price to earnings (P/E) ratio of GSK PHARMA stands at 249.7 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 12.6 times.

Equitymaster requests your view! Post a comment on "GSK PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 2.2%". Click here!

  

Related Views on News

GSK PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 398.9% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, GSK PHARMA has posted a net profit of Rs 5 bn (up 398.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 28.1% (Quarterly Result Update)

Jul 24, 2019 | Updated on Jul 24, 2019

For the quarter ended June 2019, GSK PHARMA has posted a net profit of Rs 1 bn (up 28.1% YoY). Sales on the other hand came in at Rs 8 bn (up 7.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

More Views on News

Most Popular

My View on ITC(Fast Profits Daily)

Oct 23, 2020

What do the charts say about ITC?

Why ITC and not HUL is my Idea of a Good Investment Right Now(Views On News)

Oct 15, 2020

Rahul Shah discusses HUL's lost decade and its implications for ITC.

Why India's Drone Revolution is a 4x Profit Opportunity(Profit Hunter)

Oct 16, 2020

My research on India's leading defence companies brought me to one major player in drone manufacturing.

PSU Banks Will Move Up Again(Profit Hunter)

Oct 27, 2020

My charts tell me PSU banks are set for a rebound.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Oct 28, 2020 02:32 PM

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK PHARMA 8-QTR ANALYSIS

COMPARE GSK PHARMA WITH

MARKET STATS